Positions
- Visiting Professor
-
Pathology & Immunology
Baylor College of Medicine
Education
- Advanced Training from Stanford University School Of Medicine
- 01/1995 - Stanford, CA, United States
- Ph.D. from Massachusetts Institute Of Technology
- 01/1991 - Cambridge, MA, United States
- B.A. from University Of California, San Diego
- 01/1984 - La Jolla, CA, United States
Professional Interests
- Prostate cancer progression
- Gene therapy
- CID
- Akt, fgf, caspase.
Websites
Selected Publications
-
Narayanan P, Lapteva N, Seethammagari M, Levitt JM, Slawin KM, Spencer DM. " A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy. " J. Clin. Invest.. 2011 Apr 1; 121 (4) : 1524-34.
Pubmed PMID: 21383499. -
Li B, Desai SA, MacCorkle-Chosnek RA, Fan L, Spencer DM. " A novel conditional Akt 'survival switch' reversibly protects cells from apoptosis. " Gene Ther.. 2002 Feb ; 9 (4) : 233-44.
Pubmed PMID: 11896462. -
Chen M, Orozco A, Spencer DM, Wang J. " Activation of initiator caspases through a stable dimeric intermediate. " J. Biol. Chem.. 2002 Dec 27; 277 (52) : 50761-7.
Pubmed PMID: 12399450. -
Kazansky AV, Spencer DM, Greenberg NM. " Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. " Cancer Res.. 2003 Dec 15; 63 (24) : 8757-62.
Pubmed PMID: 14695191.
Log In to edit your profile